Latest News in the pharma Industry

Market News

Tjoapack investment triples its bottling capacity

Tjoapack investment triples its bottling capacity

8 Jan 2018

Companies outsourcing their packaging requirements - particularly those in the generics market where reducing time to market is crucial - look set to reap the benefits.

Read more 
Revolutionary medical innovations being unleashed in Canada MaRS discovery district

Revolutionary medical innovations being unleashed in Canada MaRS discovery district

7 Jan 2018

Health investors are paying attention to Canada, particularly to Toronto’s hot market.

Read more 
Takeda to acquire TiGenix

Takeda to acquire TiGenix

7 Jan 2018

Acquisition will expand Takeda’s late-stage pipeline and leadership in gastroenterology.

Read more 
Sangamo and Pfizer collaborate to develop zinc finger protein gene therapy for ALS

Sangamo and Pfizer collaborate to develop zinc finger protein gene therapy for ALS

7 Jan 2018

"The precision and flexibility of zinc finger proteins enables targeting of virtually any genetic mutation."

Read more 
SSB to equip Abzena's US-based development and manufacturing sites

SSB to equip Abzena's US-based development and manufacturing sites

4 Jan 2018

SSB will provide both facilities with end-to-end process solutions in single-use format.

Read more 
Momenta and Mylan to development proposed biosimilar to Eylea

Momenta and Mylan to development proposed biosimilar to Eylea

4 Jan 2018

Targeting the initiation of a pivotal patient clinical trial in the first half of 2018.

Read more 
Junior Filters for space restricted applications

Junior Filters for space restricted applications

3 Jan 2018

Ideal for a wide variety of pharmaceutical applications.

Read more 
Scholar Rock announces $47 million Series C financing to advance innovative pipeline

Scholar Rock announces $47 million Series C financing to advance innovative pipeline

3 Jan 2018

SRK-015 to move into clinical development for Spinal Muscular Atrophy (SMA) in first half of 2018; development in additional neuromuscular disorders to follow.

Read more 
Recipharm acquires remaining shares in Nitin Lifesciences

Recipharm acquires remaining shares in Nitin Lifesciences

2 Jan 2018

The transaction will allow Recipharm to combine and better exploit operational synergies with the company's other Indian business.

Read more 
Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

2 Jan 2018

Martyn Davies recognised for his contribution to UK science and his ground-breaking achievements in pharmaceutical research and drug development.

Read more 
Novel Sorrento CAR-T technology a potential “game-changer

Novel Sorrento CAR-T technology a potential “game-changer

2 Jan 2018

Company envisions the development and IND filings of multiple “next-frontier” CAR-T programs in 2018 and beyond, which will position the company as a potential major player in the fast-growing CAR-T space of immunotherapies against cancers.

Read more 
ANVISA approves Biocon and Mylan's biosimilar Trastuzumab

ANVISA approves Biocon and Mylan's biosimilar Trastuzumab

29 Dec 2017

Libbs will commercialize the product in Brazil under the brand name Zedora.

Read more